SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-021011
Filing Date
2024-04-22
Accepted
2024-04-22 16:16:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20023138x2_defa14a.htm DEFA14A 21749
2 ny20023138x2_nc01.jpg GRAPHIC 499308
3 ny20023138x2_nc02.jpg GRAPHIC 370587
  Complete submission text file 0001140361-24-021011.txt   1220414
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40502 | Film No.: 24861387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)